NCT01462149View on ClinicalTrials.gov

Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Advanced Ovarian Cancer
Interventions
DRUG

Neoadjuvant chemotherapy

Docetaxel 75mg/m2BAS, q 3 weeks, 3 cycles

DRUG

Carboplatin

Carboplatin AUC 5, q 3 weeks, 3 cycles

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Asan Medical Center

OTHER

NCT01462149 - Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer | Biotech Hunter | Biotech Hunter